P2Y1 gene A1622G dimorphism is not associated with adenosine diphosphate-induced platelet activation and aggregation after administration of a single high dose of clopidogrel.
Sibbing
D
D
von Beckerath
O
O
Schömig
A
A
Kastrati
A
A
von Beckerath
N
N
D000244:Adenosine Diphosphate / Q000378:metabolism*; D000368:Aged; D000077144:Clopidogrel; D005260:Female; D005838:Genotype; D006801:Humans; D008297:Male; D008875:Middle Aged; D015539:Platelet Activation / Q000187:drug effects*; D010974:Platelet Aggregation / Q000187:drug effects*; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D011110:Polymorphism, Genetic; D018048:Receptors, Purinergic P2 / Q000235:genetics*; D058472:Receptors, Purinergic P2Y1; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology
C546382:P2RY1 protein, human; D010975:Platelet Aggregation Inhibitors; D018048:Receptors, Purinergic P2; D058472:Receptors, Purinergic P2Y1; D000244:Adenosine Diphosphate; D000077144:Clopidogrel; D013988:Ticlopidine